LRIG3 and hepatocellular carcinoma: Herein, we found that circ-LRIG3 was notably increased in HCC and patients with high circ-LRIG3 had shorter overall and disease-free survival time than those with low circ-LRIG3, implying that circ-LRIG3 is a prognostic biomarker of HCC.